Cargando…
Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer
Anti‐angiogenic drugs targeting the VEGF pathway are most effective in advanced metastatic disease settings of certain types of cancers, whereas they have been unsuccessful as adjuvant therapies of micrometastatic disease in numerous phase III trials involving early‐stage (resectable) cancers. Newer...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261516/ https://www.ncbi.nlm.nih.gov/pubmed/34125494 http://dx.doi.org/10.15252/emmm.201708253 |